vs
Enact Holdings, Inc.（ACT）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是Enact Holdings, Inc.的1.6倍（$493.8M vs $312.7M），Enact Holdings, Inc.同比增速更快（3.6% vs -1.7%），过去两年Enact Holdings, Inc.的营收复合增速更高（3.6% vs -0.1%）
Enact Holdings, Inc.是美国领先的私人抵押贷款保险服务商，为银行、信用社等各类住宅抵押贷款机构提供风险缓释解决方案，帮助首付较低的购房者获得可负担的住房贷款，助力更多美国普通消费者实现安居需求。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
ACT vs MD — 直观对比
营收规模更大
MD
是对方的1.6倍
$312.7M
营收增速更快
ACT
高出5.3%
-1.7%
两年增速更快
ACT
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $312.7M | $493.8M |
| 净利润 | — | $33.7M |
| 毛利率 | — | — |
| 营业利润率 | 71.3% | 9.9% |
| 净利率 | — | 6.8% |
| 营收同比 | 3.6% | -1.7% |
| 净利润同比 | — | 10.5% |
| 每股收益（稀释后） | $1.23 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACTMD
| Q4 25 | $312.7M | $493.8M | ||
| Q3 25 | $311.5M | $492.9M | ||
| Q2 25 | $304.9M | $468.8M | ||
| Q1 25 | $306.8M | $458.4M | ||
| Q4 24 | $301.8M | $502.4M | ||
| Q3 24 | $309.6M | $511.2M | ||
| Q2 24 | $298.8M | $504.3M | ||
| Q1 24 | $291.6M | $495.1M |
净利润ACTMD
| Q4 25 | — | $33.7M | ||
| Q3 25 | — | $71.7M | ||
| Q2 25 | — | $39.3M | ||
| Q1 25 | — | $20.7M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | — | $19.4M | ||
| Q2 24 | — | $-153.0M | ||
| Q1 24 | — | $4.0M |
营业利润率ACTMD
| Q4 25 | 71.3% | 9.9% | ||
| Q3 25 | 67.4% | 13.8% | ||
| Q2 25 | 70.4% | 12.8% | ||
| Q1 25 | 68.9% | 7.0% | ||
| Q4 24 | 68.9% | 7.8% | ||
| Q3 24 | 74.1% | 6.6% | ||
| Q2 24 | 78.6% | -31.3% | ||
| Q1 24 | 70.6% | 3.2% |
净利率ACTMD
| Q4 25 | — | 6.8% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 8.4% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | -30.3% | ||
| Q1 24 | — | 0.8% |
每股收益（稀释后）ACTMD
| Q4 25 | $1.23 | $0.40 | ||
| Q3 25 | $1.10 | $0.84 | ||
| Q2 25 | $1.11 | $0.46 | ||
| Q1 25 | $1.08 | $0.24 | ||
| Q4 24 | $1.05 | $0.37 | ||
| Q3 24 | $1.15 | $0.23 | ||
| Q2 24 | $1.16 | $-1.84 | ||
| Q1 24 | $1.01 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $582.5M | $375.2M |
| 总债务越低越好 | $744.5M | $570.5M |
| 股东权益账面价值 | $5.4B | $865.9M |
| 总资产 | $6.9B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.14× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资ACTMD
| Q4 25 | $582.5M | $375.2M | ||
| Q3 25 | $545.6M | $340.1M | ||
| Q2 25 | $616.0M | $224.7M | ||
| Q1 25 | $639.0M | $99.0M | ||
| Q4 24 | $602.8M | $229.9M | ||
| Q3 24 | $674.9M | $103.8M | ||
| Q2 24 | $711.3M | $19.4M | ||
| Q1 24 | $624.3M | $8.0M |
总债务ACTMD
| Q4 25 | $744.5M | $570.5M | ||
| Q3 25 | $744.1M | $577.2M | ||
| Q2 25 | $743.8M | $583.9M | ||
| Q1 25 | $743.4M | $590.5M | ||
| Q4 24 | $743.0M | $597.1M | ||
| Q3 24 | $742.7M | — | ||
| Q2 24 | $742.4M | — | ||
| Q1 24 | $746.1M | — |
股东权益ACTMD
| Q4 25 | $5.4B | $865.9M | ||
| Q3 25 | $5.3B | $890.7M | ||
| Q2 25 | $5.2B | $833.8M | ||
| Q1 25 | $5.1B | $789.2M | ||
| Q4 24 | $5.0B | $764.9M | ||
| Q3 24 | $5.0B | $732.5M | ||
| Q2 24 | $4.8B | $706.5M | ||
| Q1 24 | $4.7B | $856.2M |
总资产ACTMD
| Q4 25 | $6.9B | $2.2B | ||
| Q3 25 | $6.9B | $2.2B | ||
| Q2 25 | $6.8B | $2.1B | ||
| Q1 25 | $6.7B | $2.0B | ||
| Q4 24 | $6.5B | $2.2B | ||
| Q3 24 | $6.6B | $2.1B | ||
| Q2 24 | $6.3B | $2.0B | ||
| Q1 24 | $6.3B | $2.2B |
负债/权益比ACTMD
| Q4 25 | 0.14× | 0.66× | ||
| Q3 25 | 0.14× | 0.65× | ||
| Q2 25 | 0.14× | 0.70× | ||
| Q1 25 | 0.15× | 0.75× | ||
| Q4 24 | 0.15× | 0.78× | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $724.5M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACTMD
| Q4 25 | $724.5M | $114.1M | ||
| Q3 25 | $192.0M | $137.3M | ||
| Q2 25 | $119.5M | $137.2M | ||
| Q1 25 | $226.7M | $-117.5M | ||
| Q4 24 | $686.3M | $133.0M | ||
| Q3 24 | $188.1M | $91.8M | ||
| Q2 24 | $144.7M | $107.0M | ||
| Q1 24 | $187.3M | $-125.2M |
现金转化率ACTMD
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACT
暂无分部数据
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
